This evidence is suggestive that IL-6 is not causal and should be taken in the context that variants that alter IL-6 signaling do alter both the incidence and outcomes of other infections and that the trial evidence of IL-6 inhibition has supported the genetic evidence in COVID-19 [10,11,39]. This evidence concerns the gene IL6 and COVID-19.